From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Cliff Weight of ShareSoc, the High Class Eastern European hooker, Mark Slater & our bet

By Tom Winnifrith | Tuesday 28 June 2022


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I'm not suggesting anything inappropriate - just making an analogy, as I discuss Zephyr Energy (ZPHR). Then, I touch on Optibiotix (OPTI), and a chat with Steve O'Hara. If you'd like to spend a day with Steve over all day drink and home-produced Welsh food, you can of course do so, HERE. I am pleased to say that almost a third of the seats are already booked out. After that, it is onto Oxford Biodynamics (OBD) and Shield Therapeutics (STX) - will its placing be at 5p, or not at all?.  Then, Pennon (PNN), sewage and Feargal Sharkey. Finally, Abingdon Diagnostics (ABDX), where good news has seen the shares rocket. However, that only postpones the next bailout placing (or death) until Adven

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 12:50:31